10th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

Duke University and University of North Carolina’s 10th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium partnered with PHA through the Building Medical Education in PH program.

Date

Friday, November 2, 2018

Time

Registration & breakfast: 7-8 a.m.
Symposium: 8 a.m.-4:35 p.m.

Location

Hilton Durham,
3800 Hillsborough Road
Durham, NC 27705 (map)

Download the draft agenda

Course Overview

The field of pulmonary arterial hypertension (PAH) is a rapidly developing one, with multiple new treatments introduced in the last 20 years.  This has created a steep learning curve for pulmonologists and cardiologists treating this disease, as well as primary care physicians who must remain mindful to consider the diagnosis in their patients.  We seek to fortify the knowledge base of these physicians and other allied health professionals, keeping them abreast of the ever-changing diagnostic and treatment paradigms.  This dynamic state of the field serves to perpetuate a gap in regard to the knowledge of appropriate diagnostic procedures, proper treatment choices, and timing in advancement of care to pulmonary hypertension (PH) specialty centers.  It is imperative that those treating this specialized disease have a thoroughly grounded knowledge of the appropriate work up, treatment, and care of the PAH patients. 

The ACCP, AHA, and WHO have convened on multiple occasions to develop consensus guidelines for the diagnosis and treatment of PAH.  These guidelines have been published in prominent medical journals and presented at national meetings, thus exposing thousands of practitioners to these standardized approaches and promoting appropriate, structured care paradigms. The 10th Annual RTP Pulmonary Hypertension Symposium will reinforce the current diagnostic and management guidelines of PAH put forth by the 5th and 6th World Symposium on Pulmonary Hypertension, along with the focus on the different subgroups of PH.  The diagnosis, management, and treatment for patients with WHO group 2-5 PH will be addressed.  Also, discussion will focus on medications for PH that are available and the use of these in groups 2 and 3 PH will be addressed.   It will provide a plentiful forum for questions and discussion, so that practitioners and health care providers in attendance can have knowledge and reinforcement of appropriate care practices that can be put into practice.

Course Directors

H. James Ford, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary and Critical Care Medicine
University of North Carolina at Chapel Hill

Terry Fortin, MD
Co-Director, Pulmonary Vascular Disease Center
Associate Professor of Medicine
Division of Cardiology
Duke University Medical Center 

Invited Faculty

Raymond Benza, MD
Program Director
Advanced Heart Failure, Transplantation, Mechanical Circulatory Support & Pulmonary Vascular Diseases
Division of Cardiology
Allegheny Health Network

Talal Dahhan, MD, MSEd, FACP, FCCP
Assistant Professor of Medicine,
Pulmonary Vascular Disease Center
Division of Pulmonary, Allergy and Critical Care Medicine
Duke University Medical Center

Richard Krasuski, MD
Professor of Medicine
Division of Cardiology
Duke University Medical Center

Sheila Krishnan, DO
Assistant Professor of Medicine
Pulmonary Hypertension Program
University of North Carolina at Chapel Hill

Barbara LeVarge, MD
Assistant Professor of Medicine
Associate Director, Pulmonary Hypertension Program
University of North Carolina at Chapel Hill 

Kishan Parikh, MD
Assistant Professor of Medicine
Division of Cardiology
Duke University Medical Center

Sudarshan Rajagopal, MD, PhD
Co-Director, Duke Pulmonary Vascular Disease Center
Division of Cardiology
Duke University Medical Center

Lisa Rose-Jones, MD
Assistant Professor of Medicine, Pulmonary Hypertension Program
University of North Carolina at Chapel Hill

Jordan Whitson, MD
Medical Instructor
Division of Pulmonary, Allergy and Critical Care Medicine
Duke University Medical Center

Roham Zamanian, MD, FCCP
Associate Professor of Medicine
Director, Adult Pulmonary Hypertension Program
Vera Moulton Wall Center for Pulmonary Vascular Disease
Division of Pulmonary & Critical Care Medicine
Stanford University School of Medicine

Target Audience

This program is designed to meet the continuing education (CE) needs of pulmonologists, cardiologists, nurses, pharmacists, and other allied healthcare professionals involved in the treatment of pulmonary hypertension.

Learning Objectives

  • Describe classification of Pulmonary Hypertension, according to the World Symposium classifications and including updates from the 6th World Symposium
  • Recognize and distinguish similar disease processes that may or may not respond to Pulmonary Arterial Hypertension specific therapy
  • Identify appropriate treatment choices based on available evidence
  • Recognize when treatment responses are suboptimal and when referral to a specialty center is appropriate
  • Describe long term management of Pulmonary Arterial Hypertension patients
  • Identify multiple tools and parameters for assessing risks in Pulmonary Hypertension, including disease severity and progression
  • Describe advances in diagnostic testing and management of Pulmonary Hypertension

Joint Accreditation Statement

This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development for the advancement of patient care. In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Category 1: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 7 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

Pharmacists: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 7 ACPE credit hours. Universal Activity Numbers: JA0000655-0000-18-125-L01-P

Registration Fees*

$195: MDs and DOs
$60: Non-Physician Clinicians, Allied Health, Residents, and Fellows
$195: Industry representatives

*Registration fees include all symposium materials, breakfast, lunch and breaks.

Register Here

Accommodations and Room Rates

A block of rooms has been reserved at the Hilton Durham near Duke University, 3800 Hillsborough Road, Durham, NC 27705. Rooms are $119 per night, plus applicable taxes. The room block will be held until October 2, 2018 but may sell out prior to this date. To reserve your room at the conference rate, please call 919-564-2900 and identify yourself as part of the 10th Annual NC Research Triangle Pulmonary Hypertension Symposium.

Cancellation Policy

All cancellation requests must be submitted in writing to Christy Darnell via email (christy.darnell@duke.edu). In the event that the program is cancelled or postponed, we will not be responsible for any travel costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies, or hotels. 

After the Event

To complete all course requirements and claim continuing education credits, please do the following:

  • Complete the course evaluation.
  • Attest to your hours of completion.
  • Download your certificate.